Journal of the American Academy of Dermatology
Volume 62, Issue 6 , Pages 979-987 , June 2010

Incidence of psoriasis in children: A population-based study

  • Megha M. Tollefson, MD

      Affiliations

    • Department of Dermatology, College of Medicine, Mayo Clinic, Rochester, Minnesota
    • ,
  • Cynthia S. Crowson, MS

      Affiliations

    • Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota
    • ,
  • Marian T. McEvoy, MD

      Affiliations

    • Department of Dermatology, College of Medicine, Mayo Clinic, Rochester, Minnesota
    • ,
  • Hilal Maradit Kremers, MD, MSc

      Affiliations

    • Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationReprint requests: Hilal Maradit Kremers, MD, MSc, Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

,Accepted 9 July 2009.

References 

  1. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol. 2007;156:271–276
  2. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141:1537–1541
  3. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9:136–139
  4. Bell LM, Sedlack R, Beard CM, Perry HO, Michet CJ, Kurland LT. Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol. 1991;127:1184–1187
  5. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol. 2000;27:1247–1250
  6. Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143:1559–1565
  7. Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60:394–401
  8. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17:174–178
  9. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:450–456
  10. Smith AE, Kassab JY, Rowland Payne CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology. 1993;186:181–186
  11. Melton LJ. History of the Rochester epidemiology project. Mayo Clin Proc. 1996;71:266–274
  12. Schroeder DOK. A SAS macro which utilizes local and reference population counts appropriate for incidence, prevalence, and mortality rate calculations in Rochester and Olmsted County, Minnesota. Technical report series No. 20. Rochester (MN): Section of Medical Research Statistics, Mayo Clinic; 1982;
  13. Therneau TM. Expected survival based on hazard rates (updated). Technical report series No. 63. Rochester (MN): Department of Health Sciences Research, Mayo Clinic; 1999;
  14. Seyhan M, Coskun BK, Saglam H, Ozcan H, Karincaoglu Y. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int. 2006;48:525–530
  15. Basarab T, Munn SE, Jones RR. Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic. Br J Dermatol. 1996;135:70–73
  16. Gillard SE, Finlay AY. Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. Int J Clin Pract. 2005;59:1260–1267
  17. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1–18
  18. Burch PR, Rowell NR. Psoriasis: etiological aspects. Acta Derm Venereol. 1965;45:366–380
  19. Gunawardena DA, Gunawardena KA, Vasanthanathan NS, Gunawardena JA. Psoriasis in Sri-Lanka–a computer analysis of 1366 cases. Br J Dermatol. 1978;98:85–96
  20. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis: recognition and management. Am J Clin Dermatol. 2000;1:159–165
  21. Picardi A, Mazzotti E, Gaetano P, Cattaruzza MS, Baliva G, Melchi CF, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics. 2005;46:556–564
  22. Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr Dermatol. 2003;20:506–510
  23. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527–1534
  24. Jin Y, Zhang F, Yang S, Kong Y, Xiao F, Hou Y, et al. Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population. J Dermatol Sci. 2008;52:123–129
  25. Benson L, Baer HJ, Kaelber DC. Trends in the diagnosis of overweight and obesity in children and adolescents: 1999-2007. Pediatrics. 2009;123:e153–e158
  26. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39–47
  27. Altobelli E, Petrocelli R, Maccarone M, Altomare G, Argenziano G, Giannetti A, et al. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol. 2009;19:252–256
  28. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol. 2009;34:140–144
  29. Farber EM, Carlsen RA. Psoriasis in childhood. Calif Med. 1966;105:415–420
  30. Nyfors A, Lemholt K. Psoriasis in children: a short review and a survey of 245 cases. Br J Dermatol. 1975;92:437–442
  31. Fan X, Xiao FL, Yang S, Liu JB, Yan KL, Liang YH, et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol. 2007;21:762–765
  32. Kumar B, Jain R, Sandhu K, Kaur I, Handa S. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol. 2004;43:654–658
  33. Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18:188–198
  34. Nanda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an epidemiologic survey of 112 patients. Pediatr Dermatol. 1990;7:19–21
  35. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008;159:895–902
  36. Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol. 2008;159:1331–1337
  37. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–1741
  38. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–835
  39. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143:1493–1499
  40. Pearce DJ, Lucas J, Wood B, Chen J, Balkrishnan R, Feldman SR. Death from psoriasis: representative US data. J Dermatolog Treat. 2006;17:302–303

 Funded by an unrestricted research grant from Amgen Inc and National Institute of Arthritis and Musculoskeletal and Skin Diseases AR30582.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00946-3

doi: 10.1016/j.jaad.2009.07.029

Journal of the American Academy of Dermatology
Volume 62, Issue 6 , Pages 979-987 , June 2010

Article Tools

* Image Usage & Resolution